Djane A. Espírito-Santo , Gabriele S. Cordeiro , Lucimeire S. Santos , Rafael T. Silva , Márcia U. Pereira , Rhowena Jane B. Matos , Gilson T. Boaventura , Jairza Maria Barreto-Medeiros
{"title":"槲皮素对高脂饮食啮齿动物心血管重塑和动脉粥样硬化的心脏保护作用:一项系统综述。","authors":"Djane A. Espírito-Santo , Gabriele S. Cordeiro , Lucimeire S. Santos , Rafael T. Silva , Márcia U. Pereira , Rhowena Jane B. Matos , Gilson T. Boaventura , Jairza Maria Barreto-Medeiros","doi":"10.1016/j.cbi.2023.110700","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Cardiovascular diseases (CVD) are the leading cause of death globally, estimated at 17.9 million premature deaths. Several risk factors contribute to the development of CVD, including unhealthy diet rich in saturated fat. </span>Quercetin<span> (Q) is a important natural flavonoid<span><span><span> with cardioprotective effect. However, it is crucial to understand and clarify which dosages and intervention times quercetin promotes better cardioprotective effects when exposed to a High-Fat Diet (HFD). We aim was to carry out a review to identify and compare experimental studies that investigated the quercetin effect on cardiac parameters in rodents fed a HFD. This literature search was performed through the specialized databases PubMed, Embase, Web of Science and Lilacs in May 2022. The following information was collected and assessed: Species of animals, dietary fat content, intervention protocol (quercetin), and main results of alterations associated with cardiac change. A total of 116 articles were selected from the database and 30 articles were included in this study. The administration form of quercetin was used in the diet supplemented in 73.4% (n = 22) of the studies. The dosage ranged between 10 and 100 mg/kg, 0.01%–0.36%, and 4–8 g/kg diet. The treatment time ranged between 14 and 63 days in 48.4% studies and most of the selected studies observed changes in the: Serum concentrations of lipids (60%, n = 18) mainly decrease in TC and TG, left ventricle (LV) (16.13%, n = 5) includes attenuation of the </span>cardiac hypertrophy; inhibition of atherosclerotic progression (32%, n = 10) with decrease in lesions and plaque formation; improvement in the expression of gene and protein associated with cardiac functionality and </span>oxidative stress (51.6%; n = 16). </span></span></span><em>Q</em><span>uercetin supplementation at different concentrations/doses promotes important cardioprotective effects in experimental models exposed to a HFD. The supplemented diet was shown to be the better administration option. The methodological variation presented in the articles selected in this review proves that the most appropriate intervention protocol, as well as the most effective route of administration, promotes these effects.</span></p></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"384 ","pages":"Article 110700"},"PeriodicalIF":4.7000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardioprotective effect of the quercetin on cardiovascular remodeling and atherosclerosis in rodents fed a high-fat diet: A systematic review\",\"authors\":\"Djane A. Espírito-Santo , Gabriele S. Cordeiro , Lucimeire S. Santos , Rafael T. Silva , Márcia U. Pereira , Rhowena Jane B. Matos , Gilson T. Boaventura , Jairza Maria Barreto-Medeiros\",\"doi\":\"10.1016/j.cbi.2023.110700\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Cardiovascular diseases (CVD) are the leading cause of death globally, estimated at 17.9 million premature deaths. Several risk factors contribute to the development of CVD, including unhealthy diet rich in saturated fat. </span>Quercetin<span> (Q) is a important natural flavonoid<span><span><span> with cardioprotective effect. However, it is crucial to understand and clarify which dosages and intervention times quercetin promotes better cardioprotective effects when exposed to a High-Fat Diet (HFD). We aim was to carry out a review to identify and compare experimental studies that investigated the quercetin effect on cardiac parameters in rodents fed a HFD. This literature search was performed through the specialized databases PubMed, Embase, Web of Science and Lilacs in May 2022. The following information was collected and assessed: Species of animals, dietary fat content, intervention protocol (quercetin), and main results of alterations associated with cardiac change. A total of 116 articles were selected from the database and 30 articles were included in this study. The administration form of quercetin was used in the diet supplemented in 73.4% (n = 22) of the studies. The dosage ranged between 10 and 100 mg/kg, 0.01%–0.36%, and 4–8 g/kg diet. The treatment time ranged between 14 and 63 days in 48.4% studies and most of the selected studies observed changes in the: Serum concentrations of lipids (60%, n = 18) mainly decrease in TC and TG, left ventricle (LV) (16.13%, n = 5) includes attenuation of the </span>cardiac hypertrophy; inhibition of atherosclerotic progression (32%, n = 10) with decrease in lesions and plaque formation; improvement in the expression of gene and protein associated with cardiac functionality and </span>oxidative stress (51.6%; n = 16). </span></span></span><em>Q</em><span>uercetin supplementation at different concentrations/doses promotes important cardioprotective effects in experimental models exposed to a HFD. The supplemented diet was shown to be the better administration option. The methodological variation presented in the articles selected in this review proves that the most appropriate intervention protocol, as well as the most effective route of administration, promotes these effects.</span></p></div>\",\"PeriodicalId\":274,\"journal\":{\"name\":\"Chemico-Biological Interactions\",\"volume\":\"384 \",\"pages\":\"Article 110700\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemico-Biological Interactions\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0009279723003678\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemico-Biological Interactions","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009279723003678","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
心血管疾病(CVD)是全球死亡的主要原因,估计有1790万人过早死亡。一些危险因素导致心血管疾病的发展,包括富含饱和脂肪的不健康饮食。槲皮素是一种重要的具有心脏保护作用的天然黄酮类化合物。然而,了解和澄清槲皮素的剂量和干预时间在暴露于高脂肪饮食(HFD)时能促进更好的心脏保护作用是至关重要的。我们的目的是进行一项综述,以确定和比较研究槲皮素对喂食HFD的啮齿动物心脏参数影响的实验研究。这项文献检索于2022年5月通过专门数据库PubMed、Embase、Web of Science和Lilacs进行。收集并评估了以下信息:动物种类、膳食脂肪含量、干预方案(槲皮素)以及与心脏变化相关的变化的主要结果。从数据库中总共选择了116篇文章,30篇文章被纳入本研究。在73.4%(n=22)的研究中,在补充的饮食中使用了槲皮素的给药形式。剂量范围为10至100 mg/kg,0.01%至0.36%,4-8 g/kg。48.4%的研究中,治疗时间在14至63天之间,大多数选定的研究观察到以下变化:血清脂质浓度(60%,n=18)主要降低TC和TG,左心室(16.13%,n=5)包括心肌肥大的减轻;抑制动脉粥样硬化进展(32%,n=10),减少病变和斑块形成;与心脏功能和氧化应激相关的基因和蛋白质表达的改善(51.6%;n=16)。在暴露于HFD的实验模型中,不同浓度/剂量的槲皮素补充促进了重要的心脏保护作用。补充饮食被证明是更好的给药选择。本综述中选择的文章中提出的方法学变化证明,最合适的干预方案以及最有效的给药途径可以促进这些效果。
Cardioprotective effect of the quercetin on cardiovascular remodeling and atherosclerosis in rodents fed a high-fat diet: A systematic review
Cardiovascular diseases (CVD) are the leading cause of death globally, estimated at 17.9 million premature deaths. Several risk factors contribute to the development of CVD, including unhealthy diet rich in saturated fat. Quercetin (Q) is a important natural flavonoid with cardioprotective effect. However, it is crucial to understand and clarify which dosages and intervention times quercetin promotes better cardioprotective effects when exposed to a High-Fat Diet (HFD). We aim was to carry out a review to identify and compare experimental studies that investigated the quercetin effect on cardiac parameters in rodents fed a HFD. This literature search was performed through the specialized databases PubMed, Embase, Web of Science and Lilacs in May 2022. The following information was collected and assessed: Species of animals, dietary fat content, intervention protocol (quercetin), and main results of alterations associated with cardiac change. A total of 116 articles were selected from the database and 30 articles were included in this study. The administration form of quercetin was used in the diet supplemented in 73.4% (n = 22) of the studies. The dosage ranged between 10 and 100 mg/kg, 0.01%–0.36%, and 4–8 g/kg diet. The treatment time ranged between 14 and 63 days in 48.4% studies and most of the selected studies observed changes in the: Serum concentrations of lipids (60%, n = 18) mainly decrease in TC and TG, left ventricle (LV) (16.13%, n = 5) includes attenuation of the cardiac hypertrophy; inhibition of atherosclerotic progression (32%, n = 10) with decrease in lesions and plaque formation; improvement in the expression of gene and protein associated with cardiac functionality and oxidative stress (51.6%; n = 16). Quercetin supplementation at different concentrations/doses promotes important cardioprotective effects in experimental models exposed to a HFD. The supplemented diet was shown to be the better administration option. The methodological variation presented in the articles selected in this review proves that the most appropriate intervention protocol, as well as the most effective route of administration, promotes these effects.
期刊介绍:
Chemico-Biological Interactions publishes research reports and review articles that examine the molecular, cellular, and/or biochemical basis of toxicologically relevant outcomes. Special emphasis is placed on toxicological mechanisms associated with interactions between chemicals and biological systems. Outcomes may include all traditional endpoints caused by synthetic or naturally occurring chemicals, both in vivo and in vitro. Endpoints of interest include, but are not limited to carcinogenesis, mutagenesis, respiratory toxicology, neurotoxicology, reproductive and developmental toxicology, and immunotoxicology.